Phase I study of high dose gefitinib in patients with leptomeningeal metastases from EGFR-mutant non-small cell lung cancer

被引：0
|
作者：
Jackman, David M. [1 ]
Kesari, Santosh [1 ]
Cioffredi, Leigh-Anne [1 ]
Sequist, Lecia V. [2 ]
Rabin, Michael S. [1 ]
Lynch, Thomas J. [2 ]
Marcoux, J. P. [1 ]
Johnson, Bruce E. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S685 / S685
页数：1
相关论文
共 50 条
  • [1] A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
    Jackman, David M.
    Cioffredi, Leigh A.
    Jacobs, Lorraine
    Sharmeen, Farhana
    Morse, Linda K.
    Lucca, Joan
    Plotkin, Scott R.
    Marcoux, Paul J.
    Rabin, Michael S.
    Lynch, Thomas J.
    Johnson, Bruce E.
    Kesari, Santosh
    ONCOTARGET, 2015, 6 (06) : 4527 - 4536
  • [2] Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
    Naito, Yoichi
    Goto, Koichi
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1027 - 1040
  • [3] Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Padole, Atul
    Chen, Tianqi
    Peterson, P. Gabriel
    Piotrowska, Zofia
    Sequist, Lecia, V
    CANCERS, 2019, 11 (09)
  • [4] Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
    Wen, Lei
    Zhen, Junjie
    Shan, Changguo
    Lai, Mingyao
    Hong, Weiping
    Wang, Hui
    Ye, Mingting
    Yang, Yanying
    Li, Shaoqun
    Zhou, Zhaoming
    Zhou, Jiangfen
    Hu, Qingjun
    Li, Juan
    Tian, Xuwei
    Chen, Longhua
    Cai, Linbo
    Xie, Zhanhong
    Zhou, Cheng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [5] Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
    Lei Wen
    Junjie Zhen
    Changguo Shan
    Mingyao Lai
    Weiping Hong
    Hui Wang
    Mingting Ye
    Yanying Yang
    Shaoqun Li
    Zhaoming Zhou
    Jiangfen Zhou
    Qingjun Hu
    Juan Li
    Xuwei Tian
    Longhua Chen
    Linbo Cai
    Zhanhong Xie
    Cheng Zhou
    European Journal of Medical Research, 28
  • [6] Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases
    Yang, T. Jonathan
    Wu, Abraham J.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 134 - 137
  • [7] Leptomeningeal metastases in non-small cell lung cancer patients with EGFR mutations
    Li, Y-S.
    Jiang, B-Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Osimertinib for patients (pts) with leptomeningeal metastases (LM) from EGFR-mutant non-small cell lung cancer (NSCLC): Updated results from the BLOOM study.
    Yang, James Chih-Hsin
    Cho, Byoung Chul
    Kim, Dong-Wan
    Kim, Sang-We
    Lee, Jong-Seok
    Su, Wu-Chou
    John, Tom
    Kao, Stephen Chuan-Hao
    Natale, Ronald
    Goldman, Jonathan Wade
    Overend, Philip
    Vishwanathan, Karthick
    Ye, Xin
    Yang, Zhenfan
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chi-Lu Chiang
    Hsiang-Ling Ho
    Yi-Chen Yeh
    Cheng-Chia Lee
    Hsu-Ching Huang
    Chia-I Shen
    Yung-Hung Luo
    Yuh-Min Chen
    Chao-Hua Chiu
    Teh-Ying Chou
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5 - 14
  • [10] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chiang, Chi-Lu
    Ho, Hsiang-Ling
    Yeh, Yi-Chen
    Lee, Cheng-Chia
    Huang, Hsu-Ching
    Shen, Chia-, I
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiu, Chao-Hua
    Chou, Teh-Ying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 5 - 14
12345